{"title":"Prognostic models for breast cancer: A narrative review.","authors":"Hua Guo, Shi Wei","doi":"10.1016/j.humpath.2025.105835","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer prognostic models use a combination of risk factors to estimate the probability of patients' clinical outcomes, allowing the physicians to categorize patients into risk groups to guide clinical decision making. An ideal prognostic model would accurately predict patient survival and/or recurrence risk, taking into account a combination of clinical and pathological parameters that are readily available in the standard of care practice, thus can be widely utilized and continuously calibrated. To date, there have been many prognostic models for breast cancer proposed. These models differ in the methods of development and validation, the composition of predicting factors, the projected clinical outcomes, and their utilities. The identification of prognostic factors heavily relies on accurate assessment of pathologic characteristics of tumors, for which the pathologists' role is essential. Therefore, it is crucial to understand prognostic models in pathology practice to provide more accurate and personalized patient care. Herein, we present a narrative review of commonly used breast cancer prognostic models in clinical practice.</p>","PeriodicalId":13062,"journal":{"name":"Human pathology","volume":" ","pages":"105835"},"PeriodicalIF":2.7000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.humpath.2025.105835","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer prognostic models use a combination of risk factors to estimate the probability of patients' clinical outcomes, allowing the physicians to categorize patients into risk groups to guide clinical decision making. An ideal prognostic model would accurately predict patient survival and/or recurrence risk, taking into account a combination of clinical and pathological parameters that are readily available in the standard of care practice, thus can be widely utilized and continuously calibrated. To date, there have been many prognostic models for breast cancer proposed. These models differ in the methods of development and validation, the composition of predicting factors, the projected clinical outcomes, and their utilities. The identification of prognostic factors heavily relies on accurate assessment of pathologic characteristics of tumors, for which the pathologists' role is essential. Therefore, it is crucial to understand prognostic models in pathology practice to provide more accurate and personalized patient care. Herein, we present a narrative review of commonly used breast cancer prognostic models in clinical practice.
期刊介绍:
Human Pathology is designed to bring information of clinicopathologic significance to human disease to the laboratory and clinical physician. It presents information drawn from morphologic and clinical laboratory studies with direct relevance to the understanding of human diseases. Papers published concern morphologic and clinicopathologic observations, reviews of diseases, analyses of problems in pathology, significant collections of case material and advances in concepts or techniques of value in the analysis and diagnosis of disease. Theoretical and experimental pathology and molecular biology pertinent to human disease are included. This critical journal is well illustrated with exceptional reproductions of photomicrographs and microscopic anatomy.